Oncocyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Oncocyte and buy or sell other stocks, ETFs, and their options commission-free!

About OCX

Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. 

CEO
Joshua Riggs
CEOJoshua Riggs
Employees
49
Employees49
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
2009
Founded2009
Employees
49
Employees49

OCX Key Statistics

Market cap
83.22M
Market cap83.22M
Price-Earnings ratio
-0.80
Price-Earnings ratio-0.80
Dividend yield
—
Dividend yield—
Average volume
42.35K
Average volume42.35K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$4.75
52 Week high$4.75
52 Week low
$1.92
52 Week low$1.92

People also own

Based on the portfolios of people who own OCX. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Plug Power
Zomedica
Ideanomics
Tilray Brands
Ocugen, Inc
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.